全文获取类型
收费全文 | 1978篇 |
免费 | 127篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 17篇 |
妇产科学 | 68篇 |
基础医学 | 297篇 |
口腔科学 | 17篇 |
临床医学 | 157篇 |
内科学 | 589篇 |
皮肤病学 | 38篇 |
神经病学 | 287篇 |
特种医学 | 28篇 |
外科学 | 162篇 |
综合类 | 5篇 |
一般理论 | 1篇 |
预防医学 | 119篇 |
眼科学 | 30篇 |
药学 | 117篇 |
中国医学 | 2篇 |
肿瘤学 | 152篇 |
出版年
2023年 | 6篇 |
2022年 | 19篇 |
2021年 | 50篇 |
2020年 | 23篇 |
2019年 | 59篇 |
2018年 | 60篇 |
2017年 | 45篇 |
2016年 | 48篇 |
2015年 | 51篇 |
2014年 | 71篇 |
2013年 | 108篇 |
2012年 | 179篇 |
2011年 | 182篇 |
2010年 | 80篇 |
2009年 | 87篇 |
2008年 | 144篇 |
2007年 | 137篇 |
2006年 | 137篇 |
2005年 | 118篇 |
2004年 | 123篇 |
2003年 | 104篇 |
2002年 | 88篇 |
2001年 | 22篇 |
2000年 | 21篇 |
1999年 | 20篇 |
1998年 | 27篇 |
1997年 | 19篇 |
1996年 | 12篇 |
1995年 | 8篇 |
1994年 | 2篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1991年 | 9篇 |
1990年 | 7篇 |
1989年 | 5篇 |
1988年 | 3篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1981年 | 1篇 |
1976年 | 2篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1970年 | 4篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有2111条查询结果,搜索用时 15 毫秒
51.
Pau Abrisqueta Julio Delgado Miguel Alcoceba Ana Carla Oliveira Javier Loscertales Jose A. Hernández-Rivas Christelle Ferrà Raul Cordoba Lucrecia Yáñez Angeles Medina Cristina Motlló Gloria Iacoboni Guillermo Villacampa Marcos González Francesc Bosch 《British journal of haematology》2020,190(6):854-863
Richter syndrome (RS) is an uncommon evolution of chronic lymphocytic leukaemia (CLL) with a dismal prognosis. Clinical-biological features predicting outcome and best therapeutic approach for these patients remain to be established. In this study, 128 patients with RS, including 112 diffuse large B-cell lymphoma (DLBCL)-type RS, 15 Hodgkin lymphoma (HL)-type RS, and one plasmablastic lymphoma, were identified in 11 centres of the Spanish CLL Study Group (GELLC). The median overall survival (OS) was 5·9 months for DLBCL-type RS and 30·8 months for HL-type RS. Eastern Cooperative Oncology Group Performance Status, haemoglobin level, platelet count, serum lactate dehydrogenase and β2-microglobulin levels, tumour protein p53 (TP53) abnormalities in the CLL clone concomitant to RS, number of prior therapies, and clonal relationship between CLL and RS, were associated with OS in patients with DLBCL-type RS. A platelet count of <100 × 109/l, prior CLL therapy (0 vs. ≥1), and presence of TP53 alterations maintained an independent prognostic impact in the multivariate analysis. Patients without any of these factors had a better clinical outcome, with a median OS of 75·3 months, while patients with one or two or more of these factors presented a median OS of 25·5 and 3 months, respectively. Although OS of patients with RS is generally poor, a proportion of patients achieved prolonged survival. Treatment of RS remains a medical need, and further therapeutic approaches with novel therapies are warranted. 相似文献
52.
Vera Adema Laura Palomo Andrea Toma Olivier Kosmider Francisco Fuster-Tormo Rocío Benito Rocío Salgado Esperanza Such María José Larrayoz Blanca Xicoy Jesus Maria Hernandez-Sanchez Paolo Maietta Alexander Neef Michaela Fontenay Mariam Ibañez Maria Diez-Campelo Sara Alvarez Jaroslaw P. Maciejewski Pierre Fenaux Francesc Sole 《British journal of haematology》2020,189(4):e133-e137
53.
54.
55.
Francesc Vallribera Valls Eloi Espín Bassany Luís Miguel Jiménez-Gómez José Ribera Chavarría Manuel Armengol Carrasco 《Journal of robotic surgery》2014,8(3):277-280
Aim
To present a case of resection of a rectal tumour by a transanal robotic approach.Patient
A 58-year-old woman with a 3-cm tumour located 6 cm proximal to anal verge (uT1N0).Results
We describe the details of the surgical technique. A complete resection with adequate margins was accomplished. The defect was closed with a running suture. Operation time was 180 min. There were no complications and the patient was discharged 24 h after surgery.Conclusion
A complete resection of a rectal tumour by a robotic approach is feasible and safe. More studies are needed to clearly define the indications where this new approach can show clear advantages over other transanal resection approaches. 相似文献56.
Hugo‐Cesar Baggio Roser Sala‐Llonch Bàrbara Segura Maria‐José Marti Francesc Valldeoriola Yaroslau Compta Eduardo Tolosa Carme Junqué 《Human brain mapping》2014,35(9):4620-4634
Graph‐theoretical analyses of functional networks obtained with resting‐state functional magnetic resonance imaging (fMRI) have recently proven to be a useful approach for the study of the substrates underlying cognitive deficits in different diseases. We used this technique to investigate whether cognitive deficits in Parkinson's disease (PD) are associated with changes in global and local network measures. Thirty‐six healthy controls (HC) and 66 PD patients matched for age, sex, and education were classified as having mild cognitive impairment (MCI) or not based on performance in the three mainly affected cognitive domains in PD: attention/executive, visuospatial/visuoperceptual (VS/VP), and declarative memory. Resting‐state fMRI and graph theory analyses were used to evaluate network measures. We have found that patients with MCI had connectivity reductions predominantly affecting long‐range connections as well as increased local interconnectedness manifested as higher measures of clustering, small‐worldness, and modularity. The latter measures also tended to correlate negatively with cognitive performance in VS/VP and memory functions. Hub structure was also reorganized: normal hubs displayed reduced centrality and degree in MCI PD patients. Our study indicates that the topological properties of brain networks are changed in PD patients with cognitive deficits. Our findings provide novel data regarding the functional substrate of cognitive impairment in PD, which may prove to have value as a prognostic marker. Hum Brain Mapp 35:4620–4634, 2014. © 2014 Wiley Periodicals, Inc . 相似文献
57.
Simon Eggington Francesc Valldeoriola K. Ray Chaudhuri Keyoumars Ashkan Elena Annoni Günther Deuschl 《Journal of neurology》2014,261(1):106-116
Parkinson’s disease (PD) is a complex progressive movement disorder leading to motor and non-motor symptoms that become increasingly debilitating as the disease advances, considerably reducing quality of life. Advanced treatment options include deep brain stimulation (DBS). While clinical effectiveness of DBS has been demonstrated in a number of randomised controlled trials (RCT), evidence on cost-effectiveness is limited. The cost-effectiveness of DBS combined with BMT, versus BMT alone, was evaluated from a UK payer perspective. Individual patient-level data on the effect of DBS on PD symptom progression from a large 6-month RCT were used to develop a Markov model representing clinical progression and capture treatment effect and costs. A 5-year time horizon was used, and an incremental cost-effectiveness ratio (ICER) was calculated in terms of cost per quality-adjusted life-years (QALY) and uncertainty assessed in deterministic sensitivity analyses. Total discounted costs in the DBS and BMT groups over 5 years were £68,970 and £48,243, respectively, with QALYs of 2.21 and 1.21, giving an incremental cost-effectiveness ratio of £20,678 per QALY gained. Utility weights in each health state and costs of on-going medication appear to be the key drivers of uncertainty in the model. The results suggest that DBS is a cost-effective intervention in patients with advanced PD who are eligible for surgery, providing good value for money to health care payers. 相似文献
58.
Antonio Cano José Manuel Silvan Antonio Estévez Francesc Baró José Villero Francisco Quereda Javier Ferrer Nicolás Mendoza Rafael Sánchez-Borrego 《Maturitas》2014
Denosumab is a new drug developed for the treatment of osteoporosis. Moreover, increasing evidences link denosumab with benefits in cancer, an area of interest for those in charge of the postmenopausal health. Denosumab has shown efficacy in the control of bone loss associated with hypogonadic states created by chemotherapy in breast and other cancers. Moreover, some studies reveal efficacy in reducing the progression of metastases. A panel of experts from the Spanish Menopause Society has met to develop usage recommendations based on the best available evidence. 相似文献
59.
60.
Gil Jumbert Marcel Placidi Francesc Alzina Clivia M. Sotomayor Torres Marianna Sledzinska 《RSC advances》2021,11(32):19908
Precise patterning of 2D materials into micro- and nanostructures presents a considerable challenge and many efforts are dedicated to the development of processes alternative to the standard lithography. In this work we show a fabrication technique based on direct electron beam lithography (EBL) on MoS2 on polydimethylsiloxane (PDMS) substrates. This easy and fast method takes advantage of the interaction of the electron beam with the PDMS, which at high enough doses leads to cross-linking and shrinking of the polymer. At the same time, the adhesion of MoS2 to PDMS is enhanced in the exposed regions. The EBL acceleration voltages and doses are optimized in order to fabricate well-defined microstructures, which can be subsequently transferred to either a flexible or a rigid substrate, to obtain the negative of the exposed image. The reported procedure greatly simplifies the fabrication process and reduces the number of steps compared to standard lithography and etching. As no additional polymer, such as polymethyl methacrylate (PMMA) or photoresists, are used during the whole process the resulting samples are free of residues.Precise patterning of 2D materials into micro- and nanostructures presents a considerable challenge and many efforts are dedicated to the development of processes alternative to the standard lithography. 相似文献